Lethal Synergism between Influenza and Streptococcus pneumoniae

Area of Science:

• Infectious Diseases
• Immunology
• Pulmonology

Background:

• Bacterial pneumonia and influenza viral infections exhibit devastating synergism, a phenomenon observed for decades.
• Pathogenesis involves pulmonary epithelial barrier damage, altered receptor exposure, and exaggerated innate immune responses (cytokine storm), exacerbating lung injury.

Purpose of the Study:

• To review recent advancements in understanding the pathogenesis of lethal pneumococcal co-infection following influenza.
• To address potential therapeutic strategies and combination therapies for influenza-bacterial pneumonia co-infections.

Main Methods:

• Mini-review of current literature on influenza-pneumococcal co-infection pathogenesis.
• Summary of ongoing evaluations for therapeutic options and combination therapies.

Main Results:

• Key factors contributing to synergistic lung injury include epithelial damage and hyperinflammatory immune responses.
• Various therapeutic avenues are under investigation, including antibiotics, anti-inflammatories (corticosteroids, TLR modifiers), and antivirals.

Conclusions:

• Understanding the complex pathogenesis of this lethal co-infection is crucial for developing effective treatments.
• Combination therapies hold promise for managing severe outcomes of influenza-bacterial pneumonia synergism.